1. Home
  2. ONEW vs MOLN Comparison

ONEW vs MOLN Comparison

Compare ONEW & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$10.65

Market Cap

155.3M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$4.34

Market Cap

144.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ONEW
MOLN
Founded
2014
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
155.3M
144.0M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
ONEW
MOLN
Price
$10.65
$4.34
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$16.75
$8.38
AVG Volume (30 Days)
105.2K
2.1K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.77
N/A
Revenue
$1,872,334,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
$3.14
$374.07
P/E Ratio
$4.00
N/A
Revenue Growth
5.62
N/A
52 Week Low
$8.12
$3.36
52 Week High
$17.92
$5.36

Technical Indicators

Market Signals
Indicator
ONEW
MOLN
Relative Strength Index (RSI) 55.81 51.67
Support Level $10.23 $4.04
Resistance Level $12.51 $4.50
Average True Range (ATR) 0.68 0.13
MACD 0.19 0.05
Stochastic Oscillator 56.52 72.47

Price Performance

Historical Comparison
ONEW
MOLN

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: